2m 2m 2m 2m 2m 2m 2m
Nutra Pharma (NPHC)
OTC
$0.0002+$0.0001 (+100.00%)
Price as of Jun 22, 2026- $1.4MMarket Cap
- 100.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Nutra Pharma (NPHC)
$0.0002+$0.0001 (+100.00%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 257,612 +4.59% | 246,309 +19.82% | 205,564 -53.10% | 438,274 +348.43% | |
Cost of Revenue | 183,679 +116.53% | 84,827 -52.22% | 177,525 +9.02% | 162,842 N/A | |
Gross Profit | 196,628 -20.50% | 247,323 -37.62% | 396,455 +59.20% | 249,022 +2,841.09% | |
Sales and Marketing Expense | N/A N/A | 1.1M -4.43% | 1.2M -43.49% | 2.1M +8.09% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 10,649 +43.13% | 7,440 -59.09% | 18,188 -19.81% | 22,682 +149.69% | |
Total Operating Expenses | 1.7M +47.37% | 1.1M -12.29% | 1.3M -40.48% | 2.2M +7.99% | |
Operating Profit | -1.5M +66.47% | -878,421 -0.96% | -886,979 -53.50% | -1.9M -4.08% | |
Interest Income | 58,750 -43.21% | 103,450 +41.59% | 73,061 +350.58% | 16,215 -79.28% | |
Interest Expense | -417,190 +37.99% | -302,331 -20.64% | -380,944 +20,969.91% | -1,808 -99.62% | |
Interest Income and Expense and Net | -358,440 +80.23% | -198,881 -35.40% | -307,883 -2,237.04% | 14,407 +103.61% | |
Total Nonoperating Income and Expense | -585,054 +43.66% | -407,242 -19.58% | -506,377 -105.02% | 10.1M +190.79% | |
Income before Taxes | -2.0M +59.25% | -1.3M -7.73% | -1.4M -117.04% | 8.2M +162.44% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income from Continuing Operations Applicable to Common | -2.0M +59.25% | -1.3M -7.73% | -1.4M -117.04% | 8.2M +162.44% | |
Basic EPS and Net Income | 0.00 N/A | 0.00 N/A | 0.00 -100.00% | 0.0004 N/A | |
Diluted EPS and Net Income | 0.00 N/A | 0.00 N/A | 0.00 -100.00% | 0.0004 N/A | |
Basic Weighted Average Shares | 7.8B +1.37% | 7.7B +0.87% | 7.6B +1.39% | 7.5B +3.74% | |
Diluted Weighted Average Shares | 7.8B +1.37% | 7.7B +0.87% | 7.6B -60.16% | 19.1B +164.03% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 20,000 0.00% | 20,000 N/A | 0 N/A | N/A N/A | |
Short-Term Investments | 17,600 0.00% | 17,600 -50.00% | 35,200 N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 37,600 0.00% | 37,600 +6.82% | 35,200 N/A | 0 -100.00% | |
Total Current Assets | 459,583 +22.61% | 374,837 +19.35% | 314,060 -5.85% | 333,577 -37.51% | |
Accumulated Depreciation | 58,256 +22.37% | 47,607 +18.52% | 40,167 -83.60% | 244,867 +10.21% | |
Property and Plant and Equipment and Net | 25,805 +148.08% | 10,402 -41.70% | 17,842 -77.70% | 80,012 +78.99% | |
Total Long-Term Assets | 25,805 +148.08% | 10,402 -41.70% | 17,842 -77.70% | 80,012 +78.99% | |
Total Assets | 584,558 -2.49% | 599,495 -6.39% | 640,397 -15.17% | 754,913 -3.22% | |
Income Taxes Payable | 19,150 0.00% | 19,150 0.00% | 19,150 0.00% | 19,150 0.00% | |
Total Short-Term Debt | 9.6M +13.35% | 8.5M +1.94% | 8.3M +4.97% | 7.9M +4.39% | |
Total Current Liabilities | 17.3M +13.14% | 15.3M +7.73% | 14.2M +11.58% | 12.7M -39.92% | |
Total Long-Term Debt | 136,644 -2.55% | 140,217 -99.02% | 14.3M +5,531.09% | 254,430 -50.80% | |
Total Long-Term Liabilities | 136,644 -2.55% | 140,217 +50.11% | 93,411 -71.18% | 324,084 +119.30% | |
Total Liabilities | 17.4M +13.00% | 15.4M +6.93% | 14.4M +9.72% | 13.1M -39.36% | |
Retained Earnings | -78.3M +2.69% | -76.2M +1.72% | -74.9M +1.89% | -73.6M -10.00% | |
Total Stockholders Equity | -16.8M +13.62% | -14.8M +7.55% | -13.8M N/A | N/A N/A | |
Total Shares Outstanding | 7.1B 0.00% | 7.1B +0.50% | 7.1B +0.36% | 7.0B -3.97% | |
Cash Flow | |||||
Cash from Operating Activities | -1.2M +174.55% | -423,959 -22.92% | -550,036 -27.86% | -762,432 -56.29% | |
Capital Expenditures | 26,052 N/A | N/A N/A | N/A N/A | 57,993 +48.54% | |
Cash from Investing Activities | -51,052 -223.61% | 41,300 -64.81% | 117,355 +329.78% | 27,306 +109.30% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 1.2M +184.12% | 419,106 -3.14% | 432,681 -32.84% | 644,216 -69.74% | |
Financials Ratio | |||||
Gross Margin | 28.70% -56.22% | 65.56% +380.65% | 13.64% -78.30% | 62.84% N/A | |
Operating Margin | -567.65% +59.17% | -356.63% -17.35% | -431.49% -0.86% | -435.21% -78.61% | |
Return on Assets | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Equity | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Revenue Growth | 4.59% -76.85% | 19.82% +137.33% | -53.10% -115.24% | 348.43% +294.49% | |
Current Ratio | 0.03 +8.13% | 0.02 +10.81% | 0.02 -15.59% | 0.03 +3.95% | |
Cash Ratio | 0.001 -7.69% | 0.001 N/A | 0.00 N/A | N/A N/A | |
Debt-to-Equity Ratio | -0.58 -0.48% | -0.58 -64.58% | -1.65 N/A | N/A N/A | |
Debt-to-Assets Ratio | 16.70 +15.98% | 14.40 -59.31% | 35.38 +226.15% | 10.85 +4.23% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow